Chapter 6 - The Crash Wasn’t the Beginning Either
The witness was a mechanic named Luis Ortega.
He had serviced the SUV Mara was driving the week before the crash.
According to Richard’s investigator, Luis told a colleague the rear brake line showed signs of tampering inconsistent with ordinary wear.
Three days later he missed work.
Two weeks later he was gone from his apartment.
No public report connected his disappearance to Hale Biotech or Mara’s accident.
Maybe there wasn’t one.
Maybe there should have been.
Richard’s team had been tracing fragments for months.
Victor’s network was not made of cartoon henchmen and obvious threats. It was ordinary, which made it more dangerous: lawyers, vendors, consultants, security firms, and one or two company loyalists who believed preserving Hale Biotech justified ruthless behavior.
The more Mara learned, the less she trusted any simple answer.
Had Victor ordered the brake sabotage?
Had someone acted “helpfully” without direct instruction?
Did Valence Mercer know any of this?
Unknown.
And uncertainty had a cost: it made every accusation sound easier to dismiss.
Thomas wanted to move only on what they could prove immediately.
The hospital assault.
The undisclosed side deal.
The trust conflict.
Richard wanted to push harder.
The crash.
The old financial transfers.
The possibility that Victor engineered Richard’s near-death eight years earlier.
Mara listened to them argue and felt something unexpected.
Not comfort at having protectors.
Frustration.
Two older men with history, guilt, strategy, and pride were already beginning to shape the fight around their own priorities.
She interrupted.
“My company. My mother’s trust. My life.”
Both fell silent.
Good.
“If I’m the one you both failed, then I’m the one setting order now.”
Richard almost smiled.
Mistake.
Mara heard it in his breath.
“This is not a proud moment for you,” she said sharply.
The smile vanished.
Thomas looked as though he wanted to approve but was too wise.
Mara continued.
“First: emergency suspension of Victor’s trustee powers.”
Thomas nodded.
“Second: preserve all Valence documents and communications.”
“Yes.”
“Third: separate review of the crash, but no public accusation unless we have evidence stronger than suspicion.”
Richard opened his mouth.
Mara cut him off.
“I said no public accusation.”
He exhaled.
“Fine.”
Not agreement. Acceptance.
Then she added the thing neither liked.
“Fourth: no one speaks to the board about my readiness except me.”
Thomas hesitated.
“Mara, given your medical condition—”
She turned her face toward him.
“My eyes are bandaged. My mind is not.”
That ended it.
The next morning, the board situation deteriorated quickly.
Hale Biotech’s directors learned through counsel that Richard Hale was alive.
Panic would have been more dignified than what actually happened.
Instead:
some directors pretended measured concern,
some demanded proof,
some asked whether Richard’s reappearance could destabilize licensing discussions,
and one of Victor’s longtime allies immediately asked whether Richard’s mental competence had been independently verified.
Mara almost laughed when Thomas relayed that.
“Same playbook,” she said.
Attack condition before judgment.
Exactly what Celeste warned her about.
Then the board scheduled an emergency meeting for the following afternoon.
Mara insisted on attending by video from the hospital.
Victor’s lawyers objected that her condition made participation “medically unwise.”
Emily Foster answered that there was no medical reason Mara could not speak for thirty minutes if monitored.
Small victory.
Then another problem arrived.
The media found out Richard Hale was alive.
Not through Mara’s side.
A biotech reporter called the hospital asking for comment on “the resurrected founder.”
Victor’s people were already shaping the story.
They described Richard as an estranged man with unverified claims, returning during corporate stress to create confusion while his medically vulnerable daughter was under pressure.
Mara listened to that summary and felt cold admiration.
It was effective.
Cruel.
Effective.
Then Thomas delivered worse news.
Valence Mercer had not pulled out of the deal after hearing about the hospital incident.
In fact, they were accelerating diligence.
Why?
Because uncertainty makes aggressive investors move faster if they think assets might become cheaper or easier to restructure.
Victor was telling them the family conflict only proved why firm outside control was needed.
Real company pressure still existed.
The failed manufacturing expansion remained a drain.
Hale Biotech’s lenders wanted clarity.
The neuro-regenerative division truly was the crown jewel.
Victor wasn’t inventing the need for a transaction.
He was exploiting it.
Again, the story refused to become easy.
Then Emily returned after checking Mara’s bandages.
“Your swelling is improving.”
Mara held still.
Doctors had been careful not to promise more.
“Meaning?”
“We may be able to remove one layer and assess light response in forty-eight hours.”
Forty-eight hours.
At the center of everything else, hope entered quietly and made everything more frightening.
Because if sight returned—even partially—Victor’s narrative of helpless incapacity would weaken.
Then Richard asked if he could stay the night in the family lounge adjacent to the hospital suite.
Mara said yes.
The word came out before she had fully decided.
He did not thank her.
Good again.
Gratitude would have been too easy.
Later, long after Thomas left and the hallway quieted, Mara asked through the darkness:
“If you’d come back when Mom was alive… do you think she would’ve forgiven you?”
Richard answered from the chair by the window.
“No.”
Mara lay listening to the monitor beside her.
For some reason that honesty hurt less than everything else.
May you like
Mara took control of the legal strategy, but the board and the press were already beginning to use her blindness as a corporate narrative. In Part 7, she would face the Hale Biotech board directly—and discover that one director had been secretly helping her mother long before Celeste died.
---
